-
1
-
-
1442314095
-
Post-transplant infections now exceed acute rejection as cause for hospitalization: A report of the NAPRTCS
-
DHARNIDHARKA VR, STABLEIN DM, HARMON WE: Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS. Am. J. Transplant. (2004) 4:384-389.
-
(2004)
Am. J. Transplant.
, vol.4
, pp. 384-389
-
-
Dharnidharka, V.R.1
Stablein, D.M.2
Harmon, W.E.3
-
2
-
-
0035684413
-
Hospitalizations for fungal infections after renal transplantation in the United States
-
ABBOTT KC, HYPOLITE I, POROPATICH RK et al.: Hospitalizations for fungal infections after renal transplantation in the United States. Transpl. Infect. Dis. (2001) 3:203-211.
-
(2001)
Transpl. Infect. Dis.
, vol.3
, pp. 203-211
-
-
Abbott, K.C.1
Hypolite, I.2
Poropatich, R.K.3
-
3
-
-
0037235092
-
Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients
-
SINGH N, AVERY RK, MUNOZ P et al.: Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin. Infect. Dis. (2003) 36:46-52.
-
(2003)
Clin. Infect. Dis.
, vol.36
, pp. 46-52
-
-
Singh, N.1
Avery, R.K.2
Munoz, P.3
-
4
-
-
0037080599
-
Trends in invasive fungal infections in liver transplant recipients: Correlation with evolution in transplantation practices
-
SINGH N, WAGENER MM, MARINO IR, GAYOWSKI T: Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices. Transplantation (2002) 73:63-67.
-
(2002)
Transplantation
, vol.73
, pp. 63-67
-
-
Singh, N.1
Wagener, M.M.2
Marino, I.R.3
Gayowski, T.4
-
5
-
-
0035889523
-
Trends in the epidemiology of opportunistic fungal infections: Predisposing factors and the impact of antimicrobial use practices
-
SINGH N: Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices. Clin. Infect. Dis. (2001) 33:1692-1696.
-
(2001)
Clin. Infect. Dis.
, vol.33
, pp. 1692-1696
-
-
Singh, N.1
-
6
-
-
20844461687
-
Risk factors for invasive aspergillosis in solid-organ transplant recipients: A case-control study
-
GAVALDA J, LEN O, SAN JUAN R et al.: Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. Clin. Infect. Dis. (2005) 41:52-59.
-
(2005)
Clin. Infect. Dis.
, vol.41
, pp. 52-59
-
-
Gavalda, J.1
Len, O.2
San Juan, R.3
-
7
-
-
0030792873
-
The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients
-
Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland
-
GEORGE MJ, SNYDMAN DR, WERNER BG et al.: The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. Am. J. Med. (1997) 103:106-113.
-
(1997)
Am. J. Med.
, vol.103
, pp. 106-113
-
-
George, M.J.1
Snydman, D.R.2
Werner, B.G.3
-
8
-
-
0034720716
-
Human herpesvirus-6 in liver transplant recipients: Role in pathogenesis of fungal infections, neurologic complications, and outcome
-
ROGERS J, ROHAL S, CARRIGAN DR et al.: Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation (2000) 69:2566-2573.
-
(2000)
Transplantation
, vol.69
, pp. 2566-2573
-
-
Rogers, J.1
Rohal, S.2
Carrigan, D.R.3
-
9
-
-
0034037337
-
Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection
-
EINSELE H, HEBART H, KAUFFMANN-SCHNEIDER C et al.: Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection. Bone Marrow Transplant. (2000) 25:757-763.
-
(2000)
Bone Marrow Transplant.
, vol.25
, pp. 757-763
-
-
Einsele, H.1
Hebart, H.2
Kauffmann-Schneider, C.3
-
10
-
-
3242714014
-
Nosocomial invasive aspergillosis in a heart transplant patient acquired during a break in the HEPA air filtration system
-
MUNOZ P, GUINEA J, PELAEZ T et al.: Nosocomial invasive aspergillosis in a heart transplant patient acquired during a break in the HEPA air filtration system. Transpl. Infect. Dis. (2004) 6:50-54.
-
(2004)
Transpl. Infect. Dis.
, vol.6
, pp. 50-54
-
-
Munoz, P.1
Guinea, J.2
Pelaez, T.3
-
11
-
-
19044375724
-
Cleaning patient shower facilities: A novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic molds
-
ANAISSIE EJ, STRATTON SL, DIGNANI MC et al.: Cleaning patient shower facilities: a novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic molds. Clin. Infect. Dis. (2002) 35:E86-E88.
-
(2002)
Clin. Infect. Dis.
, vol.35
-
-
Anaissie, E.J.1
Stratton, S.L.2
Dignani, M.C.3
-
12
-
-
0037090138
-
Contamination of hospital water with Aspergillus fumigatus and other molds
-
WARRIS A, VOSS A, ABRAHAMSEN TG, VERWEIJ PE: Contamination of hospital water with Aspergillus fumigatus and other molds. Clin. Infect. Dis. (2002) 34:1159-1160.
-
(2002)
Clin. Infect. Dis.
, vol.34
, pp. 1159-1160
-
-
Warris, A.1
Voss, A.2
Abrahamsen, T.G.3
Verweij, P.E.4
-
13
-
-
0035503195
-
Nosocomial aspergillosis is waterborne
-
ANAISSIE EJ, COSTA SF: Nosocomial aspergillosis is waterborne. Clin. Infect. Dis. (2001) 33:1546-1548.
-
(2001)
Clin. Infect. Dis.
, vol.33
, pp. 1546-1548
-
-
Anaissie, J.1
Costa, S.F.2
-
14
-
-
1942469960
-
Risk factors of invasive aspergillosis after heart transplantation: Protective role of oral itraconazole prophylaxis
-
MUNOZ P, RODRIGUEZ C, BOUZA E et al.: Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis. Am. J. Transplant. (2004) 4:636-643.
-
(2004)
Am. J. Transplant.
, vol.4
, pp. 636-643
-
-
Munoz, P.1
Rodriguez, C.2
Bouza, E.3
-
15
-
-
0037774784
-
Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: Prospective, multicenter, case-controlled study
-
HUSAIN S, TOLLEMAR J, DOMINGUEZ EA et al.: Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Transplantation (2003) 75:2023-2029.
-
(2003)
Transplantation
, vol.75
, pp. 2023-2029
-
-
Husain, S.1
Tollemar, J.2
Dominguez, E.A.3
-
16
-
-
0036852162
-
Risk factors for invasive aspergillosis in liver transplant recipients
-
FORTUN J, MARTIN-DAVILA P, MORENO S et al.: Risk factors for invasive aspergillosis in liver transplant recipients. Liver Transplantation (2002) 8:1065-1070.
-
(2002)
Liver Transplantation
, vol.8
, pp. 1065-1070
-
-
Fortun, J.1
Martin-Davila, P.2
Moreno, S.3
-
17
-
-
0029811528
-
Primary liver transplantation without transfusion of red blood cells
-
CACCIARELLI TV, KEEFFE EB, MOORE DH et al.: Primary liver transplantation without transfusion of red blood cells. Surgery (1996) 120:698-704.
-
(1996)
Surgery
, vol.120
, pp. 698-704
-
-
Cacciarelli, T.V.1
Keeffe, E.B.2
Moore, D.H.3
-
18
-
-
0030811786
-
Biliary reconstruction without T tubes or stents in liver transplantation: Report of 502 consecutive cases
-
VERRAN DJ, ASFAR SK, GHENT CN, GRANT DR, WALL WJ: Biliary reconstruction without T tubes or stents in liver transplantation: report of 502 consecutive cases. Liver Transpl. Surg. (1997) 3:365-373.
-
(1997)
Liver Transpl. Surg.
, vol.3
, pp. 365-373
-
-
Verran, D.J.1
Asfar, S.K.2
Ghent, C.N.3
Grant, D.R.4
Wall, W.J.5
-
19
-
-
0035082533
-
Infectious complications in patients with the Novacor left ventricular assist system
-
GROSSI P, DALLA GD, PAGANI F et al.: Infectious complications in patients with the Novacor left ventricular assist system. Transplant. Proc. (2001) 33:1969-1971.
-
(2001)
Transplant. Proc.
, vol.33
, pp. 1969-1971
-
-
Grossi, P.1
Dalla, G.D.2
Pagani, F.3
-
20
-
-
0028789578
-
Fungal infections in left ventricular assist device recipients. Incidence, prophylaxis, and treatment
-
GOLDSTEIN DJ, EL-AMIR NG, ASHTON RC Jr et al.: Fungal infections in left ventricular assist device recipients. Incidence, prophylaxis, and treatment. ASAIO J (1995) 41:873-875.
-
(1995)
ASAIO J
, vol.41
, pp. 873-875
-
-
Goldstein, D.J.1
El-Amir, N.G.2
Ashton Jr., R.C.3
-
22
-
-
0035125641
-
Spectrum of Aspergillus infection in lung transplant recipients: Case series and review of the literature
-
MEHRAD B, PACIOCCO G, MARTINEZ FJ et al.: Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. Chest (2001) 119:169-175.
-
(2001)
Chest
, vol.119
, pp. 169-175
-
-
Mehrad, B.1
Paciocco, G.2
Martinez, F.J.3
-
23
-
-
0031956205
-
Cytomegalovirus infection is a factor for invasive aspergillosis in lung transplant recipients
-
HUSNI RN, GORDON SM, LONGWORTH DL et al.: Cytomegalovirus infection is a factor for invasive aspergillosis in lung transplant recipients. Clin. Infect. Dis. (1998) 26:753-755.
-
(1998)
Clin. Infect. Dis.
, vol.26
, pp. 753-755
-
-
Husni, R.N.1
Gordon, S.M.2
Longworth, D.L.3
-
24
-
-
0030752434
-
Saprophytic fungal infections and lung transplantation-revisited
-
PARADOWSKI LJ: Saprophytic fungal infections and lung transplantation-revisited. J. Heart Lung Transplant. (1997) 16:524-531.
-
(1997)
J. Heart Lung Transplant.
, vol.16
, pp. 524-531
-
-
Paradowski, L.J.1
-
25
-
-
0030005016
-
Aspergillus infection in single and double lung transplant recipients
-
WESTNEY GE, KESTEN S, DE HOYOS A et al.: Aspergillus infection in single and double lung transplant recipients. Transplantation (1996) 61:915-919.
-
(1996)
Transplantation
, vol.61
, pp. 915-919
-
-
Westney, G.E.1
Kesten, S.2
De Hoyos, A.3
-
26
-
-
12944291020
-
Aspergillus infections in transplant recipients
-
SINGH N, PATERSON DL: Aspergillus infections in transplant recipients. Clin. Microbiol. Rev. (2005) 18:44-69.
-
(2005)
Clin. Microbiol. Rev.
, vol.18
, pp. 44-69
-
-
Singh, N.1
Paterson, D.L.2
-
27
-
-
0037337591
-
Aspergillus infections after lung transplantation: Clinical differences in type of transplant and implications for management
-
SINGH N, HUSAIN S: Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J. Heart Lung Transplant. (2003) 22:258-266.
-
(2003)
J. Heart Lung Transplant.
, vol.22
, pp. 258-266
-
-
Singh, N.1
Husain, S.2
-
28
-
-
0141863188
-
Echinocandin antifungal drugs
-
DENNING DW: Echinocandin antifungal drugs. Lancet (2003) 362:1142-1151.
-
(2003)
Lancet
, vol.362
, pp. 1142-1151
-
-
Denning, D.W.1
-
29
-
-
0037137576
-
Comparison of caspofungin and amphotericin B for invasive candidiasis
-
MORA-DUARTE J, BETTS R, ROTSTEIN C et al.: Comparison of caspofungin and amphotericin B for invasive candidiasis. N. Engl. J. Med. (2002) 347:2020-2029.
-
(2002)
N. Engl. J. Med.
, vol.347
, pp. 2020-2029
-
-
Mora-Duarte, J.1
Betts, R.2
Rotstein, C.3
-
30
-
-
2442670343
-
Second-line therapy with caspofungin for mucosal or invasive candidiasis: Results from the caspofungin compassionate-use study
-
KARTSONIS NA, SAAH A, LIPKA CJ, TAYLOR A, SABLE CA: Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use study. J. Antimicrob. Chemother. (2004) 53:878-881.
-
(2004)
J. Antimicrob. Chemother.
, vol.53
, pp. 878-881
-
-
Kartsonis, N.A.1
Saah, A.2
Lipka, C.J.3
Taylor, A.4
Sable, C.A.5
-
31
-
-
0042410872
-
Global distribution and outcomes for Candida species causing invasive candidiasis: Results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis
-
COLOMBO AL, PERFECT J, DINUBILE M et al.: Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis. Eur. J. Clin. Microbiol. Infect. Dis. (2003) 22:470-474.
-
(2003)
Eur. J. Clin. Microbiol. Infect. Dis.
, vol.22
, pp. 470-474
-
-
Colombo, A.L.1
Perfect, J.2
Dinubile, M.3
-
33
-
-
33144458567
-
Cancidas (caspofungin acetate). Summary of product characteristics
-
Document European Public Assessment Report, The European Agency for the Evaluation of Medicinal Products
-
Cancidas (caspofungin acetate). Summary of product characteristics. Document European Public Assessment Report, The European Agency for the Evaluation of Medicinal Products, (2005).
-
(2005)
-
-
-
35
-
-
0346338386
-
Co-administration of caspofungin and cyclosporine to a kidney transplant patient with pulmonary Aspergillus infection
-
ANTTILA VJ, PIILONEN A, VALTONEN M: Co-administration of caspofungin and cyclosporine to a kidney transplant patient with pulmonary Aspergillus infection. Scand. J. Infect. Dis. (2003) 35:893-894.
-
(2003)
Scand. J. Infect. Dis.
, vol.35
, pp. 893-894
-
-
Anttila, V.J.1
Piilonen, A.2
Valtonen, M.3
-
36
-
-
19944397088
-
Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A
-
MARR KA, HACHEM R, PAPANICOLAOU G et al.: Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A. Transpl. Infect Dis. (2004) 6:110-116.
-
(2004)
Transpl. Infect Dis.
, vol.6
, pp. 110-116
-
-
Marr, K.A.1
Hachem, R.2
Papanicolaou, G.3
-
37
-
-
3543095658
-
Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections
-
SANZ-RODRIGUEZ C, LOPEZ-DUARTE M, JURADO M et al.: Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections. Bone Marrow Transplant. (2004) 34:13-20.
-
(2004)
Bone Marrow Transplant.
, vol.34
, pp. 13-20
-
-
Sanz-Rodriguez, C.1
Lopez-Duarte, M.2
Jurado, M.3
-
38
-
-
0033037922
-
Invasive aspergillosis in transplant recipients
-
PATERSON DL, SINGH N: Invasive aspergillosis in transplant recipients. Medicine (1999) 78:123-138.
-
(1999)
Medicine
, vol.78
, pp. 123-138
-
-
Paterson, D.L.1
Singh, N.2
-
39
-
-
0030931525
-
Invasive aspergillosis in liver transplant recipients in the 1990s
-
SINGH N, ARNOW PM, BONHAM A et al.: Invasive aspergillosis in liver transplant recipients in the 1990s. Transplantation (1997) 64:716-720.
-
(1997)
Transplantation
, vol.64
, pp. 716-720
-
-
Singh, N.1
Arnow, P.M.2
Bonham, A.3
-
40
-
-
0034662016
-
Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: A multicenter retrospective study
-
Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients
-
GROSSI P, FARINA C, FIOCCHI R, DALLA GD: Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. Transplantation (2000) 70:112-116.
-
(2000)
Transplantation
, vol.70
, pp. 112-116
-
-
Grossi, P.1
Farina, C.2
Fiocchi, R.3
Dalla, G.D.4
-
41
-
-
0141887303
-
Invasive aspergillosis in the setting of cardiac transplantation
-
MONTOYA JG, CHAPARRO SV, CELIS D et al.: Invasive aspergillosis in the setting of cardiac transplantation. Clin. Infect. Dis. (2003) 37(Suppl. 3):S281-S292.
-
(2003)
Clin. Infect. Dis.
, vol.37
, Issue.SUPPL. 3
-
-
Montoya, J.G.1
Chaparro, S.V.2
Celis, D.3
-
42
-
-
0036431729
-
Saprophytic fungal infections and complications involving the bronchial anastomosis following human lung transplantation
-
NUNLEY DR, GAL AA, VEGA JD et al.: Saprophytic fungal infections and complications involving the bronchial anastomosis following human lung transplantation. Chest (2002) 122:1185-1191.
-
(2002)
Chest
, vol.122
, pp. 1185-1191
-
-
Nunley, D.R.1
Gal, A.A.2
Vega, J.D.3
-
43
-
-
0037369002
-
Fungal infections in the recipients of solid organ transplantation
-
SINGH N: Fungal infections in the recipients of solid organ transplantation. Infect. Dis. Clin. North Am. (2003) 17:113-134.
-
(2003)
Infect. Dis. Clin. North Am.
, vol.17
, pp. 113-134
-
-
Singh, N.1
-
44
-
-
0027394103
-
CNS aspergillosis in organ transplantation: A clinicopathological study
-
TORRE-CISNEROS J, LOPEZ OL, KUSNE S et al.: CNS aspergillosis in organ transplantation: a clinicopathological study. J. Neurol. Neurosurg. Psy. (1993) 56:188-193.
-
(1993)
J. Neurol. Neurosurg. Psy.
, vol.56
, pp. 188-193
-
-
Torre-Cisneros, J.1
Lopez, O.L.2
Kusne, S.3
-
45
-
-
0347723792
-
Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients
-
KWAK EJ, HUSAIN S, OBMAN A et al.: Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J. Clin. Microbiol. (2004) 42:435-438.
-
(2004)
J. Clin. Microbiol.
, vol.42
, pp. 435-438
-
-
Kwak, E.J.1
Husain, S.2
Obman, A.3
-
46
-
-
0027945730
-
Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus
-
LATGE JP, KOBAYASHI H, DEBEAUPUIS JP et al.: Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus. Infect. Immun. (1994) 62:5424-5433.
-
(1994)
Infect. Immun.
, vol.62
, pp. 5424-5433
-
-
Latge, J.P.1
Kobayashi, H.2
Debeaupuis, J.P.3
-
47
-
-
0032856762
-
Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis
-
MAERTENS J, VERHAEGEN J, DEMUYNCK H et al.: Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J. Clin. Microbiol. (1999) 37:3223-3228.
-
(1999)
J. Clin. Microbiol.
, vol.37
, pp. 3223-3228
-
-
Maertens, J.1
Verhaegen, J.2
Demuynck, H.3
-
48
-
-
0028821064
-
A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis
-
STYNEN D, GORIS A, SARFATI J, LATGE JP: A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J. Clin. Microbiol. (1995) 33:497-500.
-
(1995)
J. Clin. Microbiol.
, vol.33
, pp. 497-500
-
-
Stynen, D.1
Goris, A.2
Sarfati, J.3
Latge, J.P.4
-
49
-
-
0035863167
-
Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients
-
FORTUN J, MARTIN-DAVILA P, ALVAREZ ME et al.: Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients. Transplantation (2001) 71:145-149.
-
(2001)
Transplantation
, vol.71
, pp. 145-149
-
-
Fortun, J.1
Martin-Davila, P.2
Alvarez, M.E.3
-
50
-
-
0344666747
-
False positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam
-
SULAHIAN A, TOURATIER S, RIBAUD P: False positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N. Engl. J. Med. (2003) 349:2366-2367.
-
(2003)
N. Engl. J. Med.
, vol.349
, pp. 2366-2367
-
-
Sulahian, A.1
Touratier, S.2
Ribaud, P.3
-
51
-
-
0037043655
-
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
-
HERBRECHT R, DENNING DW, PATTERSON TF et al.: Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N. Engl. J. Med. (2002) 347:408-415.
-
(2002)
N. Engl. J. Med.
, vol.347
, pp. 408-415
-
-
Herbrecht, R.1
Denning, D.W.2
Patterson, T.F.3
-
52
-
-
0037897443
-
Invasive aspergillosis in liver transplant recipients: Outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B
-
LINDEN PK, COLEY K, FONTES P, FUNG JJ, KUSNE S: Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B. Clin. Infect. Dis. (2003) 37:17-25.
-
(2003)
Clin. Infect. Dis.
, vol.37
, pp. 17-25
-
-
Linden, P.K.1
Coley, K.2
Fontes, P.3
Fung, J.J.4
Kusne, S.5
-
53
-
-
0036720272
-
Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes
-
VENKATARAMANAN R, ZANG S, GAYOWSKI T, SINGH N: Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes. Antimicrob. Agents Chemother. (2002) 46:3091-3093.
-
(2002)
Antimicrob. Agents Chemother.
, vol.46
, pp. 3091-3093
-
-
Venkataramanan, R.1
Zang, S.2
Gayowski, T.3
Singh, N.4
-
54
-
-
0036532203
-
Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients
-
MARR KA, CARTER RA, CRIPPA F, WALD A, COREY L: Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. (2002) 34:909-917.
-
(2002)
Clin. Infect. Dis.
, vol.34
, pp. 909-917
-
-
Marr, K.A.1
Carter, R.A.2
Crippa, F.3
Wald, A.4
Corey, L.5
-
56
-
-
4344560388
-
Invasive Zygomycosis in hematopoietic stem cell transplnat recipients receiving voriconazole prophylaxis
-
SIWEK GT, DODGSON KJ, DE MAGALHAES-SILVERMAN M et al.: Invasive Zygomycosis in hematopoietic stem cell transplnat recipients receiving voriconazole prophylaxis. Clin. Infect. Dis. (2004) 39:584-587.
-
(2004)
Clin. Infect. Dis.
, vol.39
, pp. 584-587
-
-
Siwek, G.T.1
Dodgson, K.J.2
De Magalhaes-Silverman, M.3
-
57
-
-
23944459559
-
Zygomycete infection following voriconazole prophylaxis
-
VAN WELL GT, VAN GROENINGEN I, DEBETS-OSSENKOPP YJ, VAN FURTH AM, ZWAAN CM: Zygomycete infection following voriconazole prophylaxis. Lancet Infect. Dis. (2005) 5:594.
-
(2005)
Lancet Infect. Dis.
, vol.5
, pp. 594
-
-
Van Well, G.T.1
Van Groeningen, I.2
Debets-Ossenkopp, Y.J.3
Van Furth, A.M.4
Zwaan, C.M.5
-
58
-
-
0041766322
-
Opportunistic mycelial fungal infections in organ transplant recipients: Emerging importance of non-Aspergillus mycelial fungi
-
HUSAIN S, ALEXANDER BD, MUNOZ P et al.: Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin. Infect. Dis. (2003) 37:221-229.
-
(2003)
Clin. Infect. Dis.
, vol.37
, pp. 221-229
-
-
Husain, S.1
Alexander, B.D.2
Munoz, P.3
-
59
-
-
0035347637
-
Cryptococcus neoformans infection in organ transplant recipients: Variables influencing clinical characteristics and outcome
-
HUSAIN S, WAGENER MM, SINGH N: Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg. Infect. Dis. (2001) 7:375-381.
-
(2001)
Emerg. Infect. Dis.
, vol.7
, pp. 375-381
-
-
Husain, S.1
Wagener, M.M.2
Singh, N.3
-
60
-
-
0031028176
-
The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein
-
ODOM A, DEL PM, PERFECT J, HEITMAN J: The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein. Antimicrob. Agents Chemother. (1997) 41:156-161.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 156-161
-
-
Odom, A.1
Del, P.M.2
Perfect, J.3
Heitman, J.4
-
61
-
-
0031934615
-
Successful treatment of disseminated cryptococcosis in a liver transplant recipient with fluconazole and flucytosine, an all oral regimen
-
SINGH N, GAYOWSKI T, MARINO IR: Successful treatment of disseminated cryptococcosis in a liver transplant recipient with fluconazole and flucytosine, an all oral regimen. Transpl. Int. (1998) 11:63-65.
-
(1998)
Transpl. Int.
, vol.11
, pp. 63-65
-
-
Singh, N.1
Gayowski, T.2
Marino, I.R.3
-
62
-
-
0036936783
-
Antifungal prophylaxis in liver transplant recipients: A randomized placebo-controlled study
-
BIANCOFIORE G, BINDI ML, BALDASSARRI R et al.: Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study. Transpl. Int. (2002) 15:341-347.
-
(2002)
Transpl. Int.
, vol.15
, pp. 341-347
-
-
Biancofiore, G.1
Bindi, M.L.2
Baldassarri, R.3
-
63
-
-
0036966931
-
Efficacy of Aspergillus galactomannan-directed preemptive therapy for the prevention of invasive aspergillosis in organ transplant recipients
-
MARINO IR, PANARELLO G, SINGH N: Efficacy of Aspergillus galactomannan-directed preemptive therapy for the prevention of invasive aspergillosis in organ transplant recipients. Transpl. Infect. Dis. (2002) 4:226-227.
-
(2002)
Transpl. Infect. Dis.
, vol.4
, pp. 226-227
-
-
Marino, I.R.1
Panarello, G.2
Singh, N.3
-
64
-
-
0031845924
-
The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients
-
VAN BURIK JH, LEISENRING W, MYERSON D et al.: The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients. Medicine (1998) 77:246-254.
-
(1998)
Medicine
, vol.77
, pp. 246-254
-
-
Van Burik, J.H.1
Leisenring, W.2
Myerson, D.3
-
65
-
-
0026597735
-
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation
-
GOODMAN JL, WINSTON DJ, GREENFIELD RA et al.: A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N. Engl. J. Med. (1992) 326:845-851.
-
(1992)
N. Engl. J. Med.
, vol.326
, pp. 845-851
-
-
Goodman, J.L.1
Winston, D.J.2
Greenfield, R.A.3
-
66
-
-
0033030924
-
Systemic mycoses during prophylactical use of liposomal amphotericin B (Ambisome) after liver transplantation
-
LORF T, BRAUN F, RUCHEL R et al.: Systemic mycoses during prophylactical use of liposomal amphotericin B (Ambisome) after liver transplantation. Mycoses (1999) 42:47-53.
-
(1999)
Mycoses
, vol.42
, pp. 47-53
-
-
Lorf, T.1
Braun, F.2
Ruchel, R.3
-
67
-
-
0035870741
-
Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy
-
SINGH N, PATERSON DL, GAYOWSKI T, WAGENER MM, MARINO IR: Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy. Transplantation (2001) 71:910-913.
-
(2001)
Transplantation
, vol.71
, pp. 910-913
-
-
Singh, N.1
Paterson, D.L.2
Gayowski, T.3
Wagener, M.M.4
Marino, I.R.5
-
68
-
-
0033812708
-
Targeted prophylaxis with amphotericin B lipid complex in liver transplantation
-
SINGHAL S, ELLIS RW, JONES SG et al.: Targeted prophylaxis with amphotericin B lipid complex in liver transplantation. Liver Transplantation (2000) 6:588-595.
-
(2000)
Liver Transplantation
, vol.6
, pp. 588-595
-
-
Singhal, S.1
Ellis, R.W.2
Jones, S.G.3
-
69
-
-
10744231098
-
Prevention of invasive fungal infections in liver transplant recipients: The role of prophylaxis with lipid formulations of amphotericin B in high-risk patients
-
FORTUN J, MARTIN-DAVILA P, MORENO S et al.: Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. J. Antimicrob. Chemother. (2003) 52:813-819.
-
(2003)
J. Antimicrob. Chemother.
, vol.52
, pp. 813-819
-
-
Fortun, J.1
Martin-Davila, P.2
Moreno, S.3
-
70
-
-
0037326390
-
Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species
-
KONTOYIANNIS DP, LEWIS RE, OSHEROV N, ALBERT ND, MAY GS: Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species. J. Antimicrob. Chemother. (2003) 51:313-316.
-
(2003)
J. Antimicrob. Chemother.
, vol.51
, pp. 313-316
-
-
Kontoyiannis, D.P.1
Lewis, R.E.2
Osherov, N.3
Albert, N.D.4
May, G.S.5
-
71
-
-
19444376971
-
Drug metabolism and variability among patients in drug response
-
WILKINSON GR: Drug metabolism and variability among patients in drug response. N. Engl. J. Med. (2005) 352:2211-2221.
-
(2005)
N. Engl. J. Med.
, vol.352
, pp. 2211-2221
-
-
Wilkinson, G.R.1
-
72
-
-
0347131358
-
Beneficial pharmacokinetic interaction between cyclosporine and itraconazole in renal transplant recipients
-
FLOREA NR, CAPITANO B, NIGHTINGALE CH et al.: Beneficial pharmacokinetic interaction between cyclosporine and itraconazole in renal transplant recipients. Transplant. Proc. (2003) 35:2873-2877.
-
(2003)
Transplant. Proc.
, vol.35
, pp. 2873-2877
-
-
Florea, N.R.1
Capitano, B.2
Nightingale, C.H.3
-
73
-
-
0028845453
-
Coadministration of ketoconazole to cyclosporin-treated kidney transplant recipients: A prospective randomized study
-
SOBH M, EL-AGROUDY A, MOUSTAFA F et al.: Coadministration of ketoconazole to cyclosporin-treated kidney transplant recipients: a prospective randomized study. Am. J. Nephr. (1995) 15:493-499.
-
(1995)
Am. J. Nephr.
, vol.15
, pp. 493-499
-
-
Sobh, M.1
El-Agroudy, A.2
Moustafa, F.3
-
74
-
-
0029089702
-
Ketoconazole to reduce the need for cyclosporine after cardiac transplantation
-
KEOGH A, SPRATT P, MCCOSKER C et al.: Ketoconazole to reduce the need for cyclosporine after cardiac transplantation. N. Engl. J. Med. (1995) 333:628-633.
-
(1995)
N. Engl. J. Med.
, vol.333
, pp. 628-633
-
-
Keogh, A.1
Spratt, P.2
Mccosker, C.3
-
75
-
-
0030898349
-
Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis
-
REICHENSPURNER H, GAMBERG P, NITSCHKE M et al.: Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis. Transplant. Proc. (1997) 29:627-28.
-
(1997)
Transplant. Proc.
, vol.29
, pp. 627-628
-
-
Reichenspurner, H.1
Gamberg, P.2
Nitschke, M.3
-
76
-
-
0037572197
-
Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients
-
MONFORTE V, ROMAN A, GAVALDA J et al.: Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients. Transplantation (2003) 75:1571-1574.
-
(2003)
Transplantation
, vol.75
, pp. 1571-1574
-
-
Monforte, V.1
Roman, A.2
Gavalda, J.3
-
77
-
-
0035881350
-
Safety of aerosolized amphotericin B lipid complex in lung transplant recipients
-
PALMER SM, DREW RH, WHITEHOUSE JD et al.: Safety of aerosolized amphotericin B lipid complex in lung transplant recipients. Transplantation (2001) 72:545-548.
-
(2001)
Transplantation
, vol.72
, pp. 545-548
-
-
Palmer, S.M.1
Drew, R.H.2
Whitehouse, J.D.3
-
78
-
-
0742287242
-
Comparative safety of amphotericin B lipid complex amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients
-
DREW RH, DODDS AE, BENJAMIN DK Jr et al.: Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients. Transplantation (2004) 77:232-237.
-
(2004)
Transplantation
, vol.77
, pp. 232-237
-
-
Drew, R.H.1
Dodds, A.E.2
Benjamin Jr., D.K.3
|